CDH2 and neoplasm: In adenocarcinoma, miR-9-5p exerts a tumour suppressive role and the epithelial-to-mesenchymal transition phenotype is achieved by low levels of miR-9-5p, which enable the upregulation of CDH2 via the transcription factor TWIST1 [50].